2-(trifluoromethyl)-1H-imidazo[4.5-b]pyrazine | 58885-00-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并吡嗪类
• 英文名称: 2-(trifluoromethyl)-1H-imidazo[4.5-b]pyrazine
• 英文别名: 2-trifluoromethyl-1H-imidazo[4,5-b]pyrazine；2-Trifluormethyl-1H-imidazo<4,5-b>pyrazin；2-(Trifluoromethyl)-1h-imidazo[4,5-b]pyrazine
• CAS: 58885-00-0
• 化学式: C₆H₃F₃N₄
• 分子量: 188.112
• InChiKey: YVWAGTSVIGRUAN-UHFFFAOYSA-N

物化性质

• 熔点：
  220-222 °C
• 沸点：
  166.0±50.0 °C(Predicted)
• 密度：
  1.79±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  54.5
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2,3-二氨基哌嗪 、 三氟乙酸 反应 16.0h， 以54%的产率得到2-(trifluoromethyl)-1H-imidazo[4.5-b]pyrazine
  参考文献：
  名称：

  Efficient syntheses of 2-fluoroalkylbenzimidazoles and -benzothiazoles

  摘要：

  We report an efficient one-step route to 2-fluoroalkylbenzimidazoles and -benzothiazoles via the condensation of fluorinated carboxylic acids and aromatic diamines or aminothiophenols. Additionally, we describe the syntheses of fluoroalkyl-azabenzimidazoles, -purines, and -imidazolopyrazines. This method is high-yielding with broad scope and is operationally simple with potential application to parallel synthesis. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2012.09.069

文献信息

• [EN] COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS<br/>[FR] COMPOSITIONS ET MÉTHODES DE PRÉPARATION ET D'UTILISATION DE DÉCOUPLEURS MITOCHONDRIAUX
  申请人：UNIV VIRGINIA PATENT FOUNDATION

  公开号：WO2018217757A1

  公开（公告）日：2018-11-29

  This disclosure provides compounds of Formula I, II, and III and pharmaceutically acceptable salts thereof for use as mitochondrial uncouplers, where the variables, e.g. R1-R9, (I) (II) (III) X1, X2, and Y1 are defined in the specification. The disclosure also provides pharmaceutical compositions comprising a compound or pharmaceutically acceptable salt of Formula I, II, or III, alone or in combination with another active compound. Compounds and compositions of Formula I, II, and III are useful for treating or preventing certain conditions responsive to mitochondrial uncoupling such as obesity, type II diabetes, fatty liver disease, insulin resistance, Parkinson's disease, ischemia reperfusion injury, heart failure, non-alcoholic fatty liver disease (NALFD), and non-alcoholic steatohepatitis (NASH). Compounds of Formula I, II, and III are also useful for regulating glucose homeostatis and insulin action.

  本公开提供了化合物I、II和III及其药学上可接受的盐，用作线粒体解偶联剂，其中变量，例如R1-R9，（I）（II）（III）X1、X2和Y1在规范中定义。本公开还提供了包含化合物或化学上可接受的盐的药物组合物，单独或与另一种活性化合物结合使用。化合物和组合物I、II和III的公式对于治疗或预防对线粒体解偶联有响应的某些疾病条件是有用的，例如肥胖症、2型糖尿病、脂肪肝病、胰岛素抵抗、帕金森病、缺血再灌注损伤、心力衰竭、非酒精性脂肪肝病（NALFD）和非酒精性脂肪性肝炎（NASH）。化合物I、II和III的公式也对调节葡萄糖稳态和胰岛素作用有用。
• TONG Y. C., J. HETEROCYCL. CHEM. <JHTC-AD>, 1975, 12, NO 6, 1127-1131
  作者：TONG Y. C.

  DOI：——

  日期：——
• COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS
  申请人：University Of Virginia Patent Foundation

  公开号：EP3630115A1

  公开（公告）日：2020-04-08
• Efficient syntheses of 2-fluoroalkylbenzimidazoles and -benzothiazoles
  作者：Olivier René、Alexandra Souverneva、Steven R. Magnuson、Benjamin P. Fauber

  DOI：10.1016/j.tetlet.2012.09.069

  日期：2013.1

  We report an efficient one-step route to 2-fluoroalkylbenzimidazoles and -benzothiazoles via the condensation of fluorinated carboxylic acids and aromatic diamines or aminothiophenols. Additionally, we describe the syntheses of fluoroalkyl-azabenzimidazoles, -purines, and -imidazolopyrazines. This method is high-yielding with broad scope and is operationally simple with potential application to parallel synthesis. (C) 2012 Elsevier Ltd. All rights reserved.